
Bitfarms, Digi Power X, and Galaxy Digital are the three Cryptocurrency stocks to watch today, according to MarketBeat’s stock screener tool. “Cryptocurrency stocks” are shares of publicly traded companies that derive significant revenue from or hold substantial assets in digital currencies — for example, crypto exchanges, miners, hardware/software providers, or firms with large Bitcoin/Ether balances. For investors, they offer equity exposure to the crypto ecosystem but carry company-specific risks and may only partially track cryptocurrency price swings due to operating, regulatory, and balance-sheet differences. These companies had the highest dollar trading volume of any Cryptocurrency stocks within the last several days.
Bitfarms (BITF)
Bitfarms Ltd. engages in the mining of cryptocurrency coins and tokens in Canada, the United States, Paraguay, and Argentina. It owns and operates server farms that primarily validates transactions on the Bitcoin Blockchain and earning cryptocurrency from block rewards and transaction fees. The company also provides electrician services to commercial and residential customers in Quebec, Canada.
Digi Power X (DGXX)
Digihost Technology Inc. operates as a blockchain technology company that focuses on digital currency mining in the United States. It mines for cryptocurrency. The company was incorporated in 2017 and is headquartered in Toronto, Canada.
Read Our Latest Research Report on DGXX
Galaxy Digital (GLXY)
Galaxy Digital Holdings Ltd. is a financial services and an investment management company, which engages in the digital asset, cryptocurrency, and block chain technology sectors. It operates through the following segments: Trading, Principal Investment, Asset Management, Investment Banking, Mining, and Corporate & Other.
Read Our Latest Research Report on GLXY
Read More
- MarketBeat’s Top Five Stocks to Own in May 2026
- Uber’s Annual Product Showcase Reveals It Is Coming for Airbnb and Booking
- Amprius Technologies Ups the Voltage on Forward Outlook
- Nuts and Bolts AI Play Gains Momentum: Astera Labs Targets Raised
- Why Lam Research Still Looks Like a Buy After a 300% Rally
- What the FDA’s Latest Proposal Means for Lilly, Novo, and Hims
